首页 正文

BMC health services research. 2025 Jun 5;25(1):808. doi: 10.1186/s12913-025-12971-8 Q32.72024

Preparing for pharmacy-based delivery of long-acting injectable antiretrovirals: a pre-implementation study

长效抗逆转录病毒注射制剂药店配送的实施前研究 翻译改进

Jennifer Cocohoba  1, Yvette Cuca  2, Elizabeth Sherman  3  4, Kelly Hester  5, George Udeani  6, Michael Sigua  7, Parya Saberi  8

作者单位 +展开

作者单位

  • 1 Department of Clinical Pharmacy, University of California San Francisco School of Pharmacy, 521 Parnassus Avenue, C-152, Box 0622, San Francisco, CA, 94143, USA. Jennifer.Cocohoba@ucsf.edu.
  • 2 Department of Community Health Systems, University of California San Francisco School of Nursing, 490 Illinois Street, Floor, Box 0608, San Francisco, CA, 94143, USA.
  • 3 Department of Pharmacy Practice, Nova Southeastern University, Barry and Judy Silverman College of Pharmacy, 3200 South University Drive, Fort Lauderdale, FL, 33328, USA.
  • 4 Division of Infectious Disease, Memorial Healthcare System, Hollywood, FL, USA.
  • 5 Department of Pharmacy Practice, Auburn University Harrison College of Pharmacy, Walker Bldg, 2316, 362 Thach Concourse, Auburn, AL, 36849, USA.
  • 6 Departments of Pharmacy Practice and Translational Medical Sciences, Texas A&M University, Schools of Pharmacy and Medicine, 1010 W Ave B, Kingsville, TX, USA.
  • 7 Department of Clinical Pharmacy, University of California San Francisco School of Pharmacy, 521 Parnassus Avenue, C-152, Box 0622, San Francisco, CA, 94143, USA.
  • 8 Division of Prevention Science, University of California San Francisco School of Medicine, 550 16th St 3rd Floor, San Francisco, CA, 94158, USA.
  • DOI: 10.1186/s12913-025-12971-8 PMID: 40474134

    摘要 中英对照阅读

    Copyright © BMC health services research. 中文内容为AI机器翻译,仅供参考!

    相关内容

    期刊名:Bmc health services research

    缩写:BMC HEALTH SERV RES

    ISSN:1472-6963

    e-ISSN:

    IF/分区:2.7/Q3

    文章目录 更多期刊信息

    全文链接
    引文链接
    复制
    已复制!
    推荐内容
    Preparing for pharmacy-based delivery of long-acting injectable antiretrovirals: a pre-implementation study